Thank you. But still not clear if the decision to

Thank you. But still not clear if the decision to capitalize implies that all past inventory expenditures can be part of the capitalization.

Meanwhile, I’ve done some more research. The pre launch inventory is inventory but can not be capitalized and so is written down to the net realisable value (being zero). When the circumstances that caused the inventories to be written down below costs no longer exist the write down is reversed.
This clearly explained in item 2.7 https://www.pwc.com/gx/en/pharma-life-science...pharma.pdf that I can not paste here. [Maybe someone else can]

Conclusion: the current inventories once qualifying for to be captalized pre launch inventories will be an asset and contribute to the equity position.

What got me off track (am unable to find it now) was that I’ve read that once written down for capitalization pre launch inventory can not be written back up. This would be a specific rule regarding pre launch inventories (qualifying for capitalization). It would not make sense that write downs on pre launch inventories not qualifying for capitalization could be reversed (general rule for inventories) while that would not be possible for written down inventories qualifying for capitalization. (@sjacobs: did you post that somewhere?).